Lv11
60 积分 2023-11-15 加入
TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure
1小时前
待确认
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1小时前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
4小时前
已完结
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies
10个月前
已完结
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
11个月前
已完结
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
1年前
已完结
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
1年前
已完结
Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myeloma
1年前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
1年前
已完结
Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
1年前
已完结
皖公网安备34019202002308
